Mwanzo524804 • BOM
add
Aurobindo Pharma Ltd
Bei iliyotangulia
₹ 1,156.90
Bei za siku
₹ 1,156.05 - ₹ 1,183.50
Bei za mwaka
₹ 959.05 - ₹ 1,592.55
Thamani ya kampuni katika soko
684.65B INR
Wastani wa hisa zilizouzwa
elfu 22.49
Uwiano wa bei na mapato
19.23
Mgao wa faida
-
Ubadilishanaji wa msingi
NSE
Habari za soko
The Straits Times
siku 2 zilizopita
Nasdaq, S&P 500 fall as China's DeepSeek AI model hits tech shares
0.47%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 77.96B | 7.99% |
Matumizi ya uendeshaji wa biashara | 34.02B | 13.51% |
Mapato halisi | 8.17B | 7.95% |
Kiwango cha faida halisi | 10.48 | -0.10% |
Mapato kwa kila hisa | 14.00 | 9.12% |
EBITDA | 15.77B | 16.15% |
Asilimia ya kodi ya mapato | 32.34% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 68.68B | -3.93% |
Jumla ya mali | 480.94B | 9.50% |
Jumla ya dhima | 172.09B | 9.41% |
Jumla ya hisa | 308.85B | — |
hisa zilizosalia | 583.84M | — |
Uwiano wa bei na thamani | 2.19 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 7.81% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 8.17B | 7.95% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer. Wikipedia
Ilianzishwa
1986
Makao Makuu
Tovuti
Wafanyakazi
26,015
